N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide
C16H20N6O3S — CID 175971325
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide
N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide (PubChem CID 175971325) has the molecular formula C16H20N6O3S and a molecular weight of 376.44 g/mol. Its IUPAC name is N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide.
Molecular Properties
| Compound Name | N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide |
|---|---|
| PubChem CID | 175971325 |
| Molecular Formula | C16H20N6O3S |
| Molecular Weight | 376.44 g/mol |
| Exact Mass | 376.13 |
| IUPAC Name | N,N-dimethyl-2-[[methyl-[(5-methyl-1H-indazol-7-yl)sulfonyl]amino]methyl]-1H-imidazole-5-carboxamide |
| SMILES | Cc1cc(S(=O)(=O)N(C)Cc2ncc(C(=O)N(C)C)[nH]2)c2[nH]ncc2c1 |
| InChI | InChI=1S/C16H20N6O3S/c1-10-5-11-7-18-20-15(11)13(6-10)26(24,25)22(4)9-14-17-8-12(19-14)16(23)21(2)3/h5-8H,9H2,1-4H3,(H,17,19)(H,18,20) |
| InChIKey | BWZAMEPOZANRPP-UHFFFAOYSA-N |
| XLogP | 1.12 |
| TPSA | 115.05 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 376.44 |
| LogP ≤ 5 | 1.12 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175971325 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.